Leucovorin + cofactor stack for autism (MTHFR/folate‑receptor autoimmune subgroup)
Berg explains that the MTHFR mutation affects 40% of people and creates a chronic underlying weakness in methylation and detoxification, leaving the brain more vulnerable to environmental insults (Tylenol, aluminum, etc.). In autism, this often manifests as frank cerebral folate deficiency, with 56–75% of patients having low brain folate despite normal blood levels. The combination of genetic weakness and autoimmune blockade starves neurons of the folate they need for normal development. Leucovorin is a synthetic but bioavailable form that can circumvent the antibody block, and the referenced trial not only improved cognition but also speech and other autistic behaviors. Berg stresses that while he typically opposes synthetic vitamins, this one makes sense because of the unique transport advantages. He also notes that vitamin D status heavily influences folate absorption, so many of these children are doubly deficient unless vitamin D is corrected.
In about 71% of autistic brains, antibodies attack the folate receptor alpha, preventing folate from entering the central nervous system. Methylfolate (the natural form) relies on the blocked receptor, but Leucovorin is a reduced folate that uses additional transporters (reduced folate carrier) to cross the blood‑brain barrier, bypassing the autoimmune blockade. Once inside, it supports methylation, neurotransmitter synthesis, and detoxification — processes that are often impaired in autism. The co‑factors B12, B6, B2, magnesium, and zinc are needed to make the folate cycle run efficiently.
If you take this medication, I would take these other co‑actors as well to optimize the results like B12, B6, B2, magnesium, zinc.

